Skip to main content
Caplight Logo









Galecto Biotech

Galecto Biotech

Public
Copenhagen, Capital Region of DenmarkHealthcarehttps://www.galecto.com

Galecto Biotech is now publicly traded

The data on this page reflects Galecto Biotech's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Oct 28, 2020

Last Round

Private Placement

Nov 10, 2025

Total Funding Raised

$527.9M

Company Overview

Galecto (NAS: GLTO) is a biotechnology company focused on developing therapeutics that target the biological processes underlying fibrosis and related diseases, including cancer.

Sector

Healthcare

AI Layer

Non-AI

Keywords

small molecule therapeutics for cancer and fibrosisgalectin-3 inhibitor developmentclinical-stage drug developmentdual ENL-YEATS and FLT3 inhibitoracute myeloid leukemia (AML) therapeuticsLOXL2 inhibitor for myelofibrosistherapeutics for liver cirrhosisoncology small molecule drug pipelinefibrotic disease drug discoverypharmaceutical licensing and partnership modeloral small molecule drug candidateinhaled galectin-3 inhibitor

Galecto Biotech Comparables

Compare Galecto Biotech with similar companies based on industry and business-model similarity.

Galecto Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ImmunoMet Therapeutics
65%
MetaNovas Biotech
57%
Aluda Pharmaceuticals
55%

Galecto Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementNov 10, 2025
IPOOct 28, 2020
Series DSep 25, 2020
Series COct 26, 2018
Series AOct 30, 2013

Galecto Biotech Investors

Notable investors and investment history

Galecto Biotech investors
InvestorRounds
Andreessen HorowitzPrivate Placement
Heartcore CapitalSeed, Series A, Series C, Series D
Soleus CapitalSeries D
Janus Henderson GroupSeries D, Private Placement
Balyasny Asset Management L.P.Private Placement
RA Capital ManagementPrivate Placement
TCG CrossoverPrivate Placement

Galecto Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Galecto Biotech Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersCopenhagen, Capital Region of Denmark
Employee Range11
Year Founded2010
Last FundingNov 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?